Updates
Profile and other details of Statutory Auditors of the Company in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular bearing number CIR/CFD/CMD/4/2015 dated September 9, 2015. Closure of Trading Window
Pursuant to clause 5 of the Code of Conduct adopted by the Company for regulating, monitoring and reporting of trading by insiders of the Company, trading window to deal in Company's shares is closed for designated persons from April 1, 2017 till the end of forty eight hours of the date the financial results (Financial Results of the Company for the fourth quarter and year ended March 31, 2017) are made public. Outcome of Board Meeting
With reference to the captioned subject and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today at 11.00 a.m. and concluded at 4.00 p.m. have considered the following: 1. Proposed appointment of new Statutory Auditors of the Company; 2. Upon receipt of request from Henkel AG,the Board of Directors of Jyothy Laboratories... Updates
Hon'ble Mumbai Bench of National Company Law Tribunal (NCLT) vide its order dated March 1, 2017 (uploaded on website of NCLT on March 9, 2017) has sanctioned the Scheme of Amalgamation of Jyothy Consumer Products Marketing Limited with Jyothy Laboratories Limited (the Company) under Section 391 to 394 of the Companies Act, 1956 and Section 230 to 232 of the Companies Act, 2013 w.e.f. April 1, 2016 being the appointed date. A copy of the aforesaid... Shift of Registered Office address of RTA
Jyothy Laboratories Ltd has informed BSE regarding "Shift of Registered Office address of RTA, Link Intime India Private Limited". Clarification
With reference to Volume variation, Jyothy Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Jyothy Laboratories Ltd
The Exchange has sought clarification from Jyothy Laboratories Ltd on February 17, 2017, with reference to Volume variation.The reply is awaited. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for M P Ramachandran Intimation of Schedule of Analyst Meet/ Conference
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Schedule of Analyst Meet/ Conference under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015".